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Abstract
Neural crest cells (NCC) give rise to much of the tissue that forms the vertebrate head and face, including cartilage and
bone, cranial ganglia and teeth. In this study we show that conditional expression of a dominant-negative (DN) form of Rho
kinase (Rock) in mouse NCC results in severe hypoplasia of the frontonasal processes and first pharyngeal arch, ultimately
resulting in reduction of the maxilla and nasal bones and severe craniofacial clefting affecting the nose, palate and lip. These
defects resemble frontonasal dysplasia in humans. Disruption of the actin cytoskeleton, which leads to abnormalities in cell-
matrix attachment, is seen in the RockDN;Wnt1-cre mutant embryos. This leads to elevated cell death, resulting in NCC
deficiency and hypoplastic NCC-derived craniofacial structures. Rock is thus essential for survival of NCC that form the
craniofacial region. We propose that reduced NCC numbers in the frontonasal processes and first pharyngeal arch, resulting
from exacerbated cell death, may be the common mechanism underlying frontonasal dysplasia.
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Introduction
The vertebrate face is largely formed from neural crest-derived
mesenchyme, covered in ectoderm, with a small endodermal
contribution (reviewed in [1]). Although the surface ectoderm and
pharyngeal endoderm have important signalling roles in the
patterning of the forming craniofacial region, it is the cranial
neural crest cells (NCC) that form most of the bone and cartilage
within the head, the teeth and the cranial ganglia. The rostral
NCC make extensive contributions to the frontonasal skeleton and
the calvaria of the skull, whereas the more caudal cranial NCC
migrate into the pharyngeal arches where they form the mandible
and maxilla, the middle ear and the hyoid bone (reviewed in [2]].
The forming craniofacial region is initially defined by a series of
swellings or prominences. The medial frontonasal prominence
forms the forehead, middle of the nose, philtrum of the upper lip
and primary palate. Three paired prominences, derived from the
first pharyngeal arch, form the lateral regions of the mid and lower
face, associated with the maxilla, the mandible and the secondary
palate [1]. In order for these initially featureless prominences to
give rise to their complex derivatives, processes of growth,
expansion and fusion have to be orchestrated. Interactions
between NCC, the surface ectoderm, mesoderm and endoderm
are all crucial for the normal development of the developing face
(reviewed in [3]]. Studies in animal models, particularly mouse
and chick, have highlighted the importance of specific signalling
cascades, including the sonic hedgehog, fibroblast growth factor
and bone morphogenetic protein pathways, in the development of
the craniofacial region [1,2].
The two Rho kinase isoforms (Rock 1 and 2) are highly
conserved serine/threonine kinases that play essential roles in
fundamental cellular processes such as contraction, adhesion,
migration, apoptosis and proliferation. Almost all of the analyses of
Rock function have been carried out in cell culture. In these in vitro
experiments, within the two-dimensional environment of the
culture dish, Rock is found at the rear of migrating cells and
regulates stress fibre and focal adhesion assembly, facilitating cell
body and trailing edge retraction [4,5]. Rock1 and Rock2 show
similar expression patterns in the developing embryo [6] and both
the Rock1 and Rock2 single knockout mice exhibit omphalocele and
open eyelids at birth [7,8], whereas only the Rock2 null mice
develop defects in development of the placenta and intra-uterine
growth retardation [7], suggesting that the two genes work co-
operatively in the development of these structures and have at least
some non-redundant functions. The data showing that Rock1/
Rock2 double heterozygotes have the same embryonic phenotype
as do the single homozygotes for Rock1 or Rock2 on some genetic
backgrounds [7–9], suggests that the overall level of Rock protein
(Rock1 or Rock2) may be critical. Rock1/Rock2 double null mice
have not been described in the literature. However, chemical
inhibition of Rock (using Y27632) in neurulating chicken and
mouse embryos results in a variety of malformations, including
brain abnormalities and neural tube defects [6]. The broad and
overlapping expression of Rock1 and Rock2 in the developing
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the embryo in the single knockouts for Rock1 or Rock2 [7–9]
suggests there may be some degree of functional redundancy.
Further studies have implicated Rock in delamination of NCC in
quail embryos [10] and in NCC migration in Xenopus and
zebrafish [11] although this has not been demonstrated in
mammalian embryos.
In this study we utilised transgenic mice that allowed cre-
mediated tissue-specific expression of dominant-negative (DN)
Rock (RockDN); [12] to explore its role in NCC using Wnt1-cre [13]
mice. In the RockDN mice, the Rho kinase RB/BH (TT) fragment
[14] is expressed under the control of the cytomegalovirus
promoter specifically blocking the function of both Rock1 and
Rock2 isoforms. The point mutations introduced into the Rock
RB/BH (TT) interact with endogenous Rock and abolish Rho
binding activity, but have no effect on the activity of related
kinases [15]. Thus, expression of Rock RB/BH (TT) can be used
to specifically block Rho kinase function in vivo. Use of Cre-loxP
technology means that the RockDN protein can be expressed in
the cell type of choice. Thus the use of these mice can bypass any
early lethality that might result from the loss of both Rock isoforms
during early development, but also overcome potential functional
redundancy. The RockDN;Wnt1-cre embryos developed severe
NCC-related defects affecting the craniofacial region including
hypoplasia of structures derived from the frontonasal prominence
and first pharyngeal arch.
Results
Specific knock-down of Rock in NCC causes severe
craniofacial malformation
The role of Rock isoforms in migrating NCC, and their
derivatives, was investigated using mice expressing a RockDN
construct [12] under the control of the Wnt1-cre driver [13],
Figure 1A. The RockDN protein RB/PH (TT) [12,14] is unable
to bind to Rho and specifically blocks Rock function [15]. Female
mice heterozygous for the RockDN construct and male mice
heterozygous for the Wnt1-cre construct were mated (Figure 1A),
with resulting litters containing embryos of the genotypes:
RockDN
+;Wnt1-cre
+ (hereafter referred to as RockDN),
RockDN
+;Wnt1-cre
2, RockDN
2;Wnt1-cre
+ and RockDN
2;Wnt1-cre
2;
the latter three genotypes were phenotypically indistinguishable
and acted as controls. To assess the efficiency of cre recombination
we evaluated the levels of the CAT gene cassette transcripts in
pharyngeal arches 1 and 2 of embryonic heads taken from
RockDN
+;Wnt1-cre
+ mutants and RockDN
+;Wnt1-cre
2 controls at
E11.5, as this tissue was rich in NCC (Figure S1 C,D).
Quantitative real time PCR revealed a significant 13 fold
reduction in levels of the CAT cassette in the mutant heads
(P=0.006), compared with transgenic embryos where cre was not
present; a reduction to almost undetectable levels (Figure 1B).
Efficient removal of the CAT cassette is consistent with expression
of dominant-negative Rock in the majority of NCC. Notably,
expression of RockDN in all cells of the embryo, by intercrossing
RockDN mice with PGK-cre mice [16] suggested that ubiquitously
blocking Rock function results in embryonic death before E9.5
(data not shown).
We reviewed craniofacial development in the RockDN;Wnt1-cre
embryos. By late gestation, RockDN embryos showed craniofacial
malformations affecting the fronto-medial aspect of the head,
although these varied in severity. The predominant feature was
mid-facial clefting in combination with hypoplasia of the
frontonasal region (Figure 2). Those with the severest phenotype
(47/54, from E11.5 to E18.5) had marked reductions of the
frontonasal region, maxilla and mandible (Figure 2 A,B). Facial
clefting was apparent in 50/54 embryos (Figure 2G and Figure S1
C–H), although in three cases this was apparent externally only as
a bifid nose (Figure S1J). At E15.5, the distance between the eyes
and the width of the frontonasal processes was larger in mutant
embryos compared to control littermates (P=4.202610
26,
Figure 2I and data not shown), consistent with hypertelorism
and broader skulls in the mutants. There was no significant
difference between the heights of the heads (data not shown). The
snout was also upturned in the RockDN embryos at E15.5, shown
by a decreased angle between the snout and the forehead when
compared to control littermates (P=3.208610
28; Figure 2 E,H,J).
There was no significant difference between the two groups for
any measurement at E11.5, despite mid-facial clefting being
apparent at that stage (data not shown).
At E17.5–E18.5, two out of four RockDN embryos had failed to
form eyelids (Figure 2B), as seen in mice null for either Rock1 or
Rock2 [7–9]. This was not unexpected, as the eyelids form from
NCC-derived mesenchyme [17]. Some abnormalities may have
occurred as secondary events. The hypertelorism observed
throughout gestation is likely to be secondary to the mid-facial
clefting as this produces a broader skull. In addition, two out of
four RockDN embryos examined at E17.5–E18.5 had exencephaly
(Figure 2B). As all embryos collected earlier in gestation had closed
cranial neural tubes, this does not suggest a primary involvement
of Rock in neural tube closure, but rather suggests secondary
opening, likely as a consequence of a defect in the NCC-derived
calvarias bones. Cartilage staining of E14.5 embryos revealed that
the nasal capsular cartilage is missing and the Meckel’s cartilage
appears shortened in the RockDN embryos (Figure 3 A,B). Bone
and cartilage staining of more mildly affected E18.5 embryos
demonstrated that the majority of the cranium was well formed
although there were subtle abnormalities in some NCC-derived
bones (Figure 3 C–F); specifically there was mis-shaping and
hypoplasia of the basisphenoid bone (Figure 3 E,F). The bones of
the nasal septum and the maxillary bones failed to meet in the
midline (double arrow in Figure 3F) and the hyoid bone was
hypoplastic (red arrow in Figure 3 C,D). Thus, expression of the
RockDN construct in NCC resulted in defects in the craniofacial
structures derived from the frontonasal prominence and the first
pharyngeal arches. Severe abnormalities of the outflow region of
the heart were also observed in all RockDN;Wnt1-cre embryos by
E11.5; these are described elsewhere (Phillips et al., manuscript in
preparation).
Figure 1. Conditional expression of RockDN in NCC. A) Strategy
for expressing RockDN construct in NCC. B) Quantitative real time PCR
for the CAT gene cassette, using RNA extracted from pharyngeal arches
1 and 2, from E11.5 mutant RockDN
+;Wnt1-cre
+ and control embryos.
There is a statistically significant (P,0.05 *), 13 fold decrease, in the
expression of the CAT box in the mutant sample, as calculated using the
one-way Anova test.
doi:10.1371/journal.pone.0037685.g001
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Inter-crossing of ROSA-EYFP mice with Wnt1-cre enabled the co-
localisation of Rock1 protein with NCC. At E9.5 Rock1 was
expressed in the neural tube and the dorsal root ganglia (Figure 4
A,D). Expression localised to the perimeter of the cells was found in
the mass of the NCC within the pharyngeal arches (Figure 4 B,E
and Figure S2 A–D) and in the frontonasal processes (Figure 4 C,F).
Rock1 immunoreactivity was most abundant, however, at the
boundaries of the NCC-derived mesenchyme with the epithelia of
the surface ectoderm and the neural ectoderm in the frontonasal
processes (arrows and arrowheads in Figure 4 C,F). Rock2 was
expressed in similar NCC-rich regions (Figure S2 E–G) confirming
that both isoforms were found in regions rich in migrating and post-
migratory NCC. By E11.5, both Rock1 and Rock2 proteins were
down-regulated in the craniofacial region (data not shown).
Reduction of NCC corresponds to defects in cranial NCC
derivatives
We used the Rosa 26R (b-galactosidase; b-gal) reporter to
investigate the extent of migration of NCC and the distribution of
their derivatives with regard to the observed craniofacial
Figure 2. Craniofacial malformations in RockDN;Wnt1-cre embryos. A,B) Severe frontonasal (arrow), maxilla and mandible hypoplasia
(arrowhead) and exencephaly (red arrow) in E17.5 RockDN;Wnt1-cre embryo (B), compared with control littermate (A). Note also the abnormally
shaped eye and absence of eyelids in the mutant embryo (magnified inserts in A and B). C,F) Lateral views show the abnormal development of the
snout in mildly affected RockDN;Wnt1-cre embryos at E18.5. Mild truncations of the frontonasal processes (arrow) and mandible (arrowhead) are
apparent. D,G) Clefting of the upper lip and nose are apparent in a frontal view of an E18.5 RockDN;Wnt1-cre embryo (G; same fetus as in F). Double
arrows are the same length in D and G highlighting the increased intra-ocular distance in RockDN;Wnt1-cre embryos. E,H,I,J) Measurements were
taken from E15.5 heads (11 control embryos, 6 severely affected RockDN;Wnt1-cre mutants and 3 mildly affected RockDN;Wnt1-cre mutants). The
distance between the eyes and the size of the angle between the nose and the forehead was measured (double arrow in E,H) and the results are
shown in graphs I and J, respectively. In both cases, the measurements in the severely affected mutant embryos were significantly different from the
controls (P,0.0001 *). There were no significant differences between controls and the mildly affected mutants for either measurement. Scale bar in
A–D,F,G=500 mm; E,H=375 mm.
doi:10.1371/journal.pone.0037685.g002
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guishable based on their external appearance. Staining for b-gal
showed normal migration of NCC towards pharyngeal arches 1
and 2 (Figure 5 A,C), suggesting that NCC induction and
delamination had occurred normally. However, there was a
reduction in b-gal expression anterior to the stream of NCC
migrating to the 1
st pharyngeal arch (Figure 5 A,C). At E9.5–
E10.5, the mutant embryos were still not reliably distinguishable
from control littermates on the basis of their craniofacial
phenotype. However, the b-gal expression was generally more
patchy in the craniofacial region of RockDN embryos examined at
E9.5–E10.5 (Figure S1 A,B and Figure S3) and there appeared to
be fewer b-gal-stained NCC in all embryos examined at this stage
(9/9). Although the frontonasal structures appeared hypoplastic in
87% of RockDN mutant embryos by E11.5–E18.5 (Figure S1 C–
H), b-gal expression was confluent in the developing facial
prominences. It was deficient, however, in the posterior parts of
the medial calvarias bones in embryos with the most severe
craniofacial phenotype (data not shown) and below the eyes
(Figure 5 K,L). In addition to the structural abnormalities already
described, the thymus was ectopically located in the cervical region
(data not shown) and the cranial ganglia were misshapen and
reduced in size (arrowheads in Figure 5 E,G,I,J and data not
shown).
The b-gal staining pattern also revealed abnormalities in NCC
distribution during the development of the pharyngeal arches. At
E8.5, the streams of NCC migrating towards the pharyngeal
arches were similar in both wild type and RockDN mutant embryos
(arrows in Figure 5 A,C). However, at E9.5, and persisting at
E10.5, the first and second pharyngeal arches were hypoplastic
and the b-gal expression in the arches was less intense and patchy
(Figure 5 E–J). These data suggest that although the formation,
delamination and early migration of NCC appeared to occur
normally at E8.5 in the RockDN mutants, NCC numbers declined
later in development.
Ectopic and exacerbated apoptosis in RockDN NCC
Reduced Rock function is associated with increased apoptosis
in developing motor neurones [12]. We therefore examined the
expression of activated caspase 3 in the developing RockDN
embryos, hypothesising that increased levels of apoptosis in the
affected tissues might explain the emergent phenotype. NCC
migration begins at E8.0 in the cranial region of mouse embryos
and is complete by the end of E9.5 [18]. At E8.5, after the first
NCC had delaminated from the neural tube, but before the
appearance of any craniofacial phenotype, there was little if any
activated caspase 3 labelling anywhere in the control embryos.
However, a few activated caspase 3-expressing, dying, cells were
observed in the frontonasal region and pharyngeal arches of
RockDN embryos at this stage (data not shown). By E9.5, and
continuing at E10.5, activated caspase 3-positive cells were
abundant in the dorsal part of the neural tube in RockDN
embryos, localising to the Wnt1-cre domain (Figure 6 A–D). This
correlates with the latter stages of NCC delamination from this
region but also continues after migration from the cranial neural
tube is complete. The mesenchymal cells within pharyngeal
arches 1–3 were compact in control embryos by E9.5. The
surface ectoderm formed a smooth layer surrounding the inner
ectomesenchyme (Figures 5F and 6 E,F). This outer layer
appeared uneven in the RockDN mutants and the mesenchymal
cells appeared loosely arranged and disorganised (Figures 5H
and 6 G,H). Similar observations were made in the frontonasal
processes of control and stage matched mutant embryos
(arrowheads in Figure 6 I–L). Examination of the craniofacial
region of RockDN embryos revealed that more than 25% of
NCC were caspase 3-positive in pharyngeal arches 1–3 and the
dorsal frontonasal prominences at E9.5 and E10.5 (Figure 6 E–
N and data not shown), compared with only occasional caspase
3-expressing cells in comparable sections from control litter-
mates (P=0.019; Figure 6 E–N and data not shown). Thus, this
high incidence of cell death likely explains the less compact
appearance of the ectomesenchyme of the pharyngeal arches
and frontonasal processes. In contrast to the elevated cell death,
analysis of cell proliferation in NCC-rich regions of the
developing craniofacial region revealed no significant differenc-
es between RockDN and control littermates at any stage
examined (P=0.433; Figure 6O and data not shown). These
data suggest that the progressive reductions in NCC numbers
observed in the craniofacial and pharyngeal regions at E9.5–
E10.5, and the hypoplasia of NCC-derived structures observed
in these regions later in development, were caused by loss of
NCC by apoptosis.
Figure 3. Abnormalities in formation of the craniofacial bones
in RockDN;Wnt1-cre embryos. A,B) In severely affected RockDN;Wnt1-
cre embryos at E14.5, the frontonasal bones (stained with alcian blue)
are absent (arrow in B, compare to A). Meckel’s cartilage is also reduced
in size (arrowhead in B, compare with A). C,D) Bone (red) and cartilage
(blue) staining of a mildly affected RockDN;Wnt1-cre embryo at E18.5
(D), shows that the maxilla (arrowhead) and mandibular (arrow) bones
are well formed, although the hyoid bone (red arrow) is reduced in size
in mutant embryos. E,F) Inferior views of the base of the skull in mildly
affected embryos shows that the basisphenoid and the presphenoid
bones are hypoplastic in RockDN;Wnt1-cre embryos, whereas the nasal
septum is completely missing. Moreover, the maxillary bones are widely
separated in mutant embryos (double arrow in F), compared to control
littermates (E). bs=basisphenoid; n=nasal septum; ps=presphenoid.
Scale bar=500 mm.
doi:10.1371/journal.pone.0037685.g003
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NCC death in craniofacial tissues of RockDN;Wnt1-cre
embryos
As Rock is a key regulator of the actin cytoskeleton, and
disruption of the actin cytoskeleton has been linked to induction of
cell death in a variety of contexts [19] we carried out phalloidin
staining for filamentous actin in sections taken from E9.5 control
and RockDN embryos, as this was the stage when cell death was at
its peak. In control embryos, filamentous actin was found in a
marked cortical distribution, lining the perimeter of the cell, in the
NCC-derived ectomesenchyme of the pharyngeal arches (Figure 7
A,E) and frontonasal region (Figure 7 C,G), as well as the non-
NCC-derived neural ectoderm of these regions. Cortical
phalloidin staining was markedly reduced in the mesenchyme
of the pharyngeal arches (Figure 7 B,F) and frontonasal processes
(Figure 7 D,H) of stage-matched RockDN embryos, but was found
in the same pattern as the controls in the neural ectoderm, which
is not derived from NCC (Figure 7 G,H). Moreover, there were
foci of intense phalloidin staining scattered throughout the
ectomesenchyme of the pharyngeal arches and frontonasal
process of mutant embryos, which were rarely seen in control
embryos (blue arrow in Figure 7 F,H). These foci of rounded up,
intensely phalloidin-stained cells were interspersed with activated
caspase 3-expressing cells (white arrow in Figure 7 F,H), with
occasional phalloidin-intense cells also expressing activated
caspase 3 (arrowheads in Figure 7 F,H). Thus, disruption of
the actin cytoskeleton is associated with cell death in the
craniofacial region.
In cell culture, vinculin localises to integrin-mediated focal
adhesion complexes, linking the internal cytoskeleton of the cell to
the substrate on which it sits, and also, at lower levels, in cadherin-
mediated cell-cell junctions (reviewed in [20]). As detachment of
cells from the matrix has been observed in RockDN-expressing
motor neurones [12], we looked for evidence of disruption of cell-
matrix adhesion, as a possible cause of the cell death we observe in
the craniofacial region of RockDN mutants. Whereas in cultured
NCC, vinculin localised to distinct foci at the periphery of the cells
as expected (data not shown), this was not the case in the three
dimensional environment of the developing embryo. In control
embryos, vinculin was expressed strongly in discrete regions of the
tissue, associated with boundaries between different cell types, such
as the boundary between the NCC-derived ectomesenchyme and
the neural ectoderm (Figure 7 K,O). Lower levels were also found
at the periphery of individual cells, likely reflecting its association
with cadherin-based cell-cell junctions. In matched RockDN
Figure 4. Expression of Rock1 in the developing head. A–F) D–F are magnified regions from A–C, respectively. At E9.5, Rock1 protein (red) is
expressed in the neural tube and the dorsal root ganglia, where it colocalises with Wnt1-cre+ve NCC (green, detected by GFP antibody, arrows in
A,D), and in the pharyngeal tissue (B,E). In the frontonasal processes (C,F) Rock1 is expressed at the boarders of NCC rich ectomesenchyme and the
surface ectoderm (arrows) and neural ectoderm (arrowheads), which are devoid of NCC. G) The position of the transverse sections shown in A–C are
illustrated on a cartoon of an E9.5 embryo. Line i represents the position through the neural tube (A) and pharyngeal arch 1 (B) and line ii is the level
of the fronotnasal processes (C). drg=dorsal root ganglia; fnp=frontonasal processes; mes=mesenchyme; ne=neural ectoderm; nt=neural tube;
pa1=pharyngeal arch 1; se=surface ectoderm. Scale bar in A–C=45 mm.
doi:10.1371/journal.pone.0037685.g004
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ectoderm boundary but was expressed more broadly in the NCC-
derived ectomesenchyme, in both the first pharyngeal arch
(Figure 7 I,J,M,N) and in the frontonasal region (Figure 7
K,L,O,P). Ectopic vinculin expression was also found in the
surface ectoderm of the frontonasal region and pharyngeal arches
(Figure 7 J,L). Co-staining for vinculin and activated-caspase 3
showed some localisation within the same areas, suggesting a
possible link between disruption of the actin cytoskeleton, cell-
substrate adhesion and cell death of the RockDN-expressing NCC.
Staining for paxillin, another component of focal adhesions,
confirmed these observations (Figure 8 A–H). Paxillin was
localised to the ectomesenchyme : neural ectoderm boundary
and individual cell membranes in control embryos (Figure 8 A,C).
However, staining was lost from the ectomesenchyme : neural
ectoderm boundary in RockDN embryos and was observed in
punctate foci in the ectomesenchyme (Figure 8 F,H) in a similar
distribution to activated-caspase 3 immunoreactivity, supporting
the idea that cell death was occurring at sites of abnormal focal
adhesion formation. Immuno-staining for laminin confirmed that
the interactions with the extracellular matrix were abnormal, as
basal lamina localisation was lost from the ectomesenchyme :
neural ectoderm boundary in the frontonasal processes and was
abnormally distributed throughout the surface ectoderm in both
the frontonasal processes and the pharyngeal arches (Figure 8 I–L
and data not shown).
Discussion
We have shown a cell-autonomous requirement for Rock
function within NCC in the development of the frontal aspect of
the face, and that in the absence of this, there is increased cell
death within the forming facial protuberances leading to
hypoplasia and midline facial clefting. Cell-extracellular matrix
adhesion, and specifically the distribution of focal adhesion
proteins and the basement membrane protein laminin, is
abnormal in the ectomesenchyme from RockDN mutants. Rock is
known to play important roles in modulating the cytoskeleton [4,5]
and the induction of stress fibres by the RhoA-Rock pathway is
required for the formation of focal adhesions [21]. Thus, the cell
death resulting from Rock inhibition is likely to be a secondary
consequence of cytoskeletal disorganisation, as the NCC lose
adhesion to the surrounding extracellular matrix, round up, and
die. Similarly, reduced neuronal survival and apoptotic cell death
are seen when Rock function is abrogated in developing motor
neurons [12]. These authors suggested that anoikis, cell death as a
result of failing to interact with the surrounding matrix, occurs in
the absence of Rock; we also favour this as the mechanism leading
to high levels of cell death in the RockDN;Wnt1-cre embryos
described here.
Although the role of focal adhesions has been well explored in
the two-dimensional environment of the culture dish, little is
known about the role of focal adhesions within living tissues. In
cells in three-dimensional matrices, focal adhesions cannot be
Figure 5. b-gal staining of NCC (blue) in RockDN;Wnt1-cre embryos. A–D) At E8.5, the numbers of NCCs migrating towards pharyngeal arches
1 and 2 (arrows in A,C) and within pharyngeal arch 1 (B and D) are similar. There is a reduction in NCCs populating the region anterior to the
developing eye (asterisks in A,C). E–H) At E9.5, there is increased distance between the frontonasal regions and the first pharyngeal arch (double
arrows in E,G). There is a reduction in the numbers of NCC in the head (asterisks in G, compare to E) and the first pharyngeal arch (F,H). The surface
ectoderm (arrowheads in F,H) is thickened and uneven in the mutant (compare H with F). I,J) At E10.5, the hypoplasia of the frontal region is more
obvious in severely affected RockDN;Wnt1-cre embryos and the pharyngeal arches are frequently hypoplastic (numbered 1, 2 and * (posterior
pharyngeal arches 3–6)). The cranial ganglia are misshapen and smaller in size in RockDN;Wnt1-cre embryos (white arrowheads in E,G,I,J). K,L)B y
E13.5, abnormalities in the distribution of NCC are seen even in the more mildly affected embryos, with reduced b-gal staining observed in the
midline of the forming calvarias bones (arrows) and below the eye (white arrowheads). The frontonasal region is mildly truncated. pa1=pharyngeal
arch 1; 1=pharyngeal arch 1; 2=pharyngeal arch 2. Scale bar in A,C=200 mm; B,D=2 mm; E,G=160 mm; F,H=40 mm; I–L=600 mm.
doi:10.1371/journal.pone.0037685.g005
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developing craniofacial region of normal mouse embryos, we
mainly detected vinculin localised to the boundaries between
different cell types, for example the region between the
ectomesenchyme and ectoderm of the developing frontonasal
process. These boundaries are the sites of basement membranes,
which are specialisations of the extracellular matrix that provide
structural support for the surrounding tissues, and where cell-
adhesion to the matrix is crucial [23]. The basement membrane
component laminin, was found in a similar distribution to vinculin
at these tissue boundaries in the craniofacial region of control
embryos. Laminin and vinculin were lost from the ectomesench-
yme : neural ectoderm boundary in the frontonasal processes, but
were markedly elevated in the surface ectoderm of both this region
and the pharyngeal arches. Thus, the relationship between the
ectomesenchyme and neighbouring tissue types appears to be
disrupted. This potential role for Rock1 at the basement
membrane is supported by a recent publication [24] that has
shown that Rock1 regulates basement membrane placement at the
basal surface of the epithelium of the developing salivary gland,
playing a role in establishing polarity within the tissue. In this
scenario, Rock inhibition resulted in accumulation of basement
membrane proteins throughout the epithelium [24]. Similarly, we
see excessive vinculin and laminin within the surface ectoderm,
Figure 6. Ectopic and excessive cell death in E9.5 RockDN;Wnt1-cre embryos. A–D are sections through the neural tube (line i in M), E–H
through the pharyngeal arch 1 (line i in M) and I–L through the frontonasal processes (line ii in M). A,C,E,G,I,K show caspase 3-expressing cells (red)
and Wnt1-cre+ve NCCs (green). B,D,F,H,J,L are the same sections but only showing the caspase 3-expressing cells. A–D) Whereas only very occasional
activated caspase 3-expressing, dying, cells (red) are seen in the neural epithelium in control embryos, there are many dying cells observed in the
dorsal part of the neural tube, from which the NCC emerge, in RockDN;Wnt1-cre mutant embryos (arrows in C and D). E–L) Very few activated
caspase3-expressing cells are observed in the NCC-derived ectomesenchyme of pharyngeal arch 1 (E,F) and the frontonasal region (I,J) in control
embryos. In contrast, many dying cells are seen in corresponding regions from RockDN;Wnt1-cre mutants (G,H,K,L). The surface ectoderm in the
mutant is more irregular, compared to controls (arrowheads in E,G,I,K) and the inner NCC-derived ectomesenchyme is loosely arranged with gaps
between the cells (arrows in G,K). N,O) The mean apoptotic and mitotic indexes were calculated for NCC within E9.5 pharyngeal arches. There is a
significant increase in cell death in the mutant samples compared to controls (P=0.019; * in N). There is no significant difference in cell proliferation
between the two samples (P=0.433; O). Scale bar=50 mm.
doi:10.1371/journal.pone.0037685.g006
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the frontonasal processes, suggesting Rock1 may be playing a
similar roles in restricting basement membrane to the basal surface
of the epithelium in the developing craniofacial region. The
knockdown of Rock only in the ectomesenchyme (NCC) in our
mutant, suggests that this effect can be non-cell autonomous.
Figure 7. Disruption of the actin cytoskeleton and vinculin-containing focal contacts in E9.5 RockDN;Wnt1-cre embryos. A,B,E,F,I,J,M,N
(line i in Q) are sections from first pharyngeal arch and C,D,G,H,K,L,O,P (line ii in Q) are from the frontonasal processes. A–H show phalloidin (red) and
caspase 3 (green) immunofluorescence, with E–H being magnified regions as shown by the boxes in A–D, respectively. I–L show vinculin (red) and
caspase 3 (green) dual immunofluorescence, with M–P being magnified regions as shown by boxes in I–L. The dotted lines in C,D,G,H,K,L,O,P indicate
the boundary between the inner ectomesenchyme and the neural ectoderm and the surface ectoderm. A–H) Filamentous actin, labelled with
phalloidin (red) outlines the cells in NCC-derived ectomesenchyme and neural ectoderm in the first pharyngeal arch (A,E) and frontonasal processes
(C,G) of control embryos. Cortical phalloidin staining is lost in the ectomesenchyme from RockDN;Wnt1-cre mutants (F,H) but is maintained in the
neural ectoderm (compare G with H). In addition, intense phalloidin-labelled foci are observed throughout the ectomesenchyme of the RockDN;Wnt1-
cre mutants (dense red foci, blue arrow in F,H). Green caspase 3-positive cells are interspersed (white arrow) and overlapping with the phalloidin-
intense cells (arrowheads in F,H). I–L) Vinculin and caspase 3 staining. In the pharyngeal arch the vinculin staining is not restricted to the centre of the
arch in the mutant (compare J with I). In the frontonasal processes vinculin outlines the boundary between the surface ectoderm and the neural
ectoderm with the inner NCC-derived ectomesenchyme (dotted lines in K,L). This discrete vinculin staining is lost in the RockDN;Wnt1-cre mutants
(compare P with O). cas3=activated caspase-3; mes=mesenchyme; ne=neural ectoderm; phall=phalloidin; se=surface ectoderm; vin=vinculin.
Scale bar=50 mm.
doi:10.1371/journal.pone.0037685.g007
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another component of focal adhesions, were found in condensed
foci in the ectomesenchyme of RockDN mutants, which were
intermingled with dying cells. Thus, increased cell death was
associated with disruption of the cytoskeleton and abnormal
distribution of focal-adhesion proteins. The observation that only a
small number of phalloidin/paxillin-rich condensed foci co-
expressed activated-caspase 3 likely relates to the role the latter
plays in the process of cell death, regulating chromatin conden-
sation and DNA fragmentation [25]. Thus, activated-caspase 3
would only be expected in the ectomesenchymal cells in the latter
stages of cell death. We propose that in contrast, the disruption of
focal adhesion and cytoskeletal proteins, and the consequent
detachment from the surrounding matrix, is the cause of the cell
death, and thus would be apparent within the tissue for much
longer. Rac1 has also been implicated in playing an essential role
in regulating cell-matrix adhesion in NCC [26] and Rac1
f/f;Wnt1-
cre embryos develop similar craniofacial abnormalities as the
RockDN;Wnt1-cre embryos. Excessive cell death, in combination
with disrupted NCC-matrix adhesion was observed in the in the
frontonasal region at E11.5 in these embryos, once the midfacial
clefting was apparent, although the authors did not look earlier,
before the defects arose. Together, these data suggest that it is the
defect in the interaction of NCC with the surrounding matrix, with
the multiple effects that this has on the tissue, that is the crucial
factor in the development of the craniofacial malformations
observed.
Frontonasal dysplasia has been described as a consequence of
loss of expression of certain transcription factors, including Alx3 and
Alx4. Although alone, Alx3 null mice have no phenotype, severe
midfacial clefting and truncation of the snout is observed when the
mice are inter crossed with Alx4 null mice (Alx3
+/2;Alx4
2/2 and
Alx3
2/2;Alx4
2/2; [27]). Excessive cell death was observed in the
frontonasal processes at E10.0, beforethe appearance of the defects,
as we have observed in RockDN;Wnt1-cre mice. Similarly, embryos
null for the related transcription factor Cart1, when combined with
loss of Alx4 (Alx4
2/2;Cart1
+/2 and Alx4
2/2;Cart1
2/2), also display
a similar phenotype, with severe midfacial clefting and open eyes at
birth [28], as we see in the RockDN;Wnt1-cre embryos. Brachyrrhine
(3H1 Br/+) mice display frontonasal dysplasia, thought to be caused
Figure 8. Disruption of focal adhesions and extracellular matrix in E9.5 RockDN;Wnt1-cre embryos. A,B,E,F are sections of the first
pharyngeal arch (line i in O) and C,D,G,H,I–N are from the frontonasal processes (line ii in O). A–H) E–H are magnified regions shown in the boxes on
A–D, respectively. Paxillin has a cortical distribution in the first pharyngeal arch in the control embryos (A,E) and also marks the boundary between
the neural ectoderm and NCC-derived ectomesenchyme (arrow in C,G) in the frontonasal processes. This boundary staining is lost in the mutant
(arrow in D,H) and there are intense paxillin positive foci in the pharyngeal arch and frontonasal processes (arrowheads in B,F,D,H), confirming losso f
cell-substrate adhesion. I–L) Laminin was lost from the ectomesenchyme-neural ectoderm boundary (compare arrowhead in J with L) and was
abnormally distributed in the surface ectoderm in the frontonasal processes in the RockDN;Wnt1-cre embryos (compare arrow in I with K). The H&E
staining of the same sections are shown in M and N, allowing visualisation of the different cellular layers. fnp=frontonasal process; pa1=first
pharyngeal arch; ne=neural ectoderm; se=surface ectoderm; mes=mesenchyme. Scale bar in A–D,I,K=50 mm; M,N=40 mm.
doi:10.1371/journal.pone.0037685.g008
Rho Kinase and Neural Crest Cell Survival
PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e37685by loss of the developmentally important transcription factor Six2
[29–31], although in this case associated with reduced proliferation
in the craniofacial region, rather than increased cell death [30].
Nevertheless, the consequences of reduced proliferation and
excessive cell death in a particular tissue are similar, with an overall
reduction in cell numbers relative to normal controls. Thus, a
reduction in the numbers of NCC within the developing midface
appears to be the critical factor for the development of frontonasal
dysplasia.
Conclusions
Rodent models of craniofacial abnormalities represent a
valuable tool for studying, understanding and ultimately prevent-
ing human malformations. For example, mutations in ALX3,
whose mouse counterpart has been implicated in the development
of the midface [27] also cause frontorhiny, a form of midfacial
clefting in humans [32]. Our study suggests an important role for
Rock and other regulators of the cytoskeleton in maintaining
normal craniofacial morphogenesis. In humans, frontonasal
dysplasia (OMIM: 136760) is considered to be a sporadic event,
supporting the idea that craniofacial malformations have a
complex aetiology. Although there are no reports of mutations
in ROCK1 or ROCK2 in patients with craniofacial malformations,
loss of both chromosome 18q and 2p (where ROCK1 and ROCK2
reside, respectively) result in a spectrum of abnormalities that
include hypertelorism, palatal defects and micrognathia and
cardiac (OMIM 218340 and 601808). Thus, haploinsufficiency
for these genes might contribute to the phenotype of these patients.
From our data, and a review of the current literature relating to
frontonasal dysplasia and midface clefting resulting from muta-
tions in a range of different genes, we suggest that the common
link is a reduction in NCC in the developing frontonasal
prominences and first pharyngeal arch, in many cases related to
increased NCC apoptosis. The key roles that Rho kinase plays in
regulating the cytoskeleton and maintaining cell-matrix interac-
tions suggests that it may be a common downstream effector in this
cell death process.
Materials and Methods
Ethics Statement
Ethical approval of animal work carried out in this project has
been authorised by the Newcastle University Ethics Committee
and was covered by Project Licence PPL 60/3876 approved by
the UK Home Office.
Mice and embryos
Rock dominant-negative (RockDN) mice [12] (BRC no. 01294)
from RIKEN BioResource Center (Tsukuba, Japan) were inter-
crossed with the Rosa 26R reporter line [33], ROSA-EYFP line [34],
Wnt1-cre line [13] or the PGK-cre line [16]. Mice were maintained
according to the Animals (Scientific Procedures) Act 1986, United
Kingdom. Genotyping for RockDN positive mice was performed as
described [12]. CD1 mice were obtained from Charles River.
Stage matched mutant and control embryos were used for all
experiments.
Quantitative real-time PCR
The relative quantities of the CAT gene cassette was measured
by quantitative real time PCR. RNA was extracted from four
E11.5 control and four mutant pharyngeal arches 1 and 2 using
the Trizol reagent kit (Invitrogen) in duplicate. cDNA was
produced using 1 mg of RNA with an initial DNase treatment
step (Invitrogen DNase kit) followed by reverse transcription
(Invitrogen SuperScript II RTase kit). Random 15-mers were used
(Sigma).
Quantitative real-time PCR was performed using a 7900ht fast
real-time PCR system (Applied Biosystems) and the SYBR green
JumpStart Taq ReadyMix kit (Sigma). All reactions were
performed in triplicate. Two housekeeping genes were used for
normalisation, b-actin and GAPDH, and were found to be stably
expressed in this experimental setting. Relative quantities of gene
expression were calculated using the DDCt method. Primer
sequences were for b-actin,F :5 9-GCTGGTCGTCGACAACG-
GCTC-39,R :5 9-CAAACATGATCTGGGTCATCTTTTC-39,
for GAPDH F:59-GCTGGTCGTCGACAACGGCTC-39, R:59-
CAAACATGATCTGGGTCATCTTTTC-39 and for CAT prim-
ers see [12].
Head Measurements
Heads were collected from E15.5 embryos, digital protographs
were taken, and measurements were made using ImageJ software
[35].
Histology and skeletal staining
b-gal staining of RockDN;Rosa 26R embryos was performed as
described previously [36]. For skeletal staining, the superficial
muscle layers, eyes and internal organs were removed before fixing
in Bouin’s solution. E18.5 embryos were dehydrated in 95%
ethanol and washed in acetone before staining for cartilage in
alcian blue for eight days. Bone was stained with alizarin red.
E14.5 embryos were washed with 70% ethanol/0.1% NH4OH
and cartilage stained in 0.05% alcian blue/5% acetic acid.
Embryos were imaged in either glycerol or benzyl alcohol/
benzylbenzoate.
Immunohistochemistry
Immunolabelling was performed on PFA-fixed, paraffin-em-
bedded sections using the Rock2 antibody (Santa Cruz Biotech-
nology). Cryosections were labelled using antibodies raised against
activated Rock1 (abcam), caspase 3 (Cell Signalling), vinculin
(Sigma), paxillin (abcam), laminin (Sigma), GFP-FITC (Molecular
Probes) and filamentous actin was stained with rhodamine-
phalloidin (Sigma). Each experiment was repeated a minimum
of three times and included appropriate controls.
The mean percentage cell death and cell proliferation was
calculated from three matched sections of the first pharyngeal arch
from four control and four mutant E9.5 embryos.
Statistical analysis
Statistical analysis was carried out using SPSS (IBM). The one
way ANOVA test and one sample t-test were used as appropriate.
Supporting Information
Figure S1 Craniofacial phenotype in RockDN;Wnt1-cre
embryos. Neural crest cells and their derivatives are stained blue
in each case. A,B) The frontonasal region is hypoplastic in RockDN
embryos at E9.5. C–F) Clefting of the midface is obvious in
RockDN embryos at E11.5 and E13.5, with wide separation of the
lateral prominences (white lines in D,F). There is also marked
hypertelorism (double arrows in E,F). G–J) In some mildly affected
mutants, the facial clefting in RockDN mutants is apparent only as a
midline cleft lip and a bifid nasal tip (white arrows in H,J).
Hyperteleorism is still apparent in these more mildly affected
embryos however (double headed arrows in G,H; arrows are same
length in each case). I and J are magnified images of the
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e37685frontonasal region from embryos in G and H respectively. Scale
bar in A–D=200 mm; E,F=330 mm; G,H=400 mm.
(TIF)
Figure S2 Expression of Rock1 in the pharyngeal arch
and Rock2 in the developing craniofacial region at
E10.5. A–D) Rock1 (red) is expressed throughout the pharyngeal
arch at E9.5 (A,B) and E10.5 (C,D). E–G) Rock2 protein is
expressed in and around the dorsal root ganglia, adjacent to the
neural tube (E), within pharyngeal arch 1 (F), and within the
ectomesenchyme of the frontonasal processes (G). fnp=frontona-
sal process; nt=neural tube; pa1=pharyngeal arch 1. Scale bar
A–E=50 mm.
(TIF)
Figure S3 NCC in the frontonasal region at E9.5 in
RockDN;Wnt1-cre embryos. A,B) The intensity of NCC (blue)
in the frontonasal processes (arrow) is reduced in the
RockDN;Wnt1-cre mutant embryo (B) compared to the wildtype
littermate (A). C) Shows the position of the section shown on an
E9.5 embryo. e=eye. Scale bar=50 mm.
(TIF)
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